Filana Therapeutics, Inc. Common Stock

FLNANASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.89 USD
↘ 0.04 (4.50%)🟢LIVE (AS OF 03:23 PM EDT)
🟢Market: OPEN

Shares of Filana Therapeutics, Inc. Common Stock (FLNA) are trading at $0.89. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Key drivers include negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, FLNA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 2, 2026.

Open?$0.92
High?$1.00
Low?$0.87
Prev. Close?$0.93
Volume?846.9K
Avg. Volume?3.9M
VWAP?$0.89
Rel. Volume?0.22x
Bid / Ask
Bid?$0.83 × 2.3K
Ask?$0.90 × 1.0K
Spread?$0.06
Midpoint?$0.87
Valuation & Ratios
Market Cap?44.9M
Shares Out?48.3M
Float?45.8M
Float %?94.9%
P/E Ratio?N/A
P/B Ratio?0.71
EPS?-$0.88
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Themes
Biotech - Drug Development›Neuroscience & CNSBiotech - Drug Development›Rare Disease Therapeutics
Employees
20
Market Cap
45.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.filanatx.com
Listed
2000-07-14
Address
6801 N CAPITAL OF TEXAS HIGHWAY
AUSTIN, TX 78731
Phone: 512-501-2444
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?13.57%High
Short Interest?6.2M
Days to Cover?18.7
Free Float45.8M
Avg Daily Volume332.7K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.08Strong
Quick Ratio?2.08Strong
Cash Ratio?2.06Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.71CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-66.5%WEAK▾
ROA?
S&P
3
-40.7%WEAK▾
Cash Flow & Enterprise
FCF?$-29304000
Enterprise Value?$-37754657
Fundamentals ratios updated end of day
MarketsMoversWatchlist